期刊文献+

SPINK6蛋白在人乳腺癌细胞MCF-7中的表达与定位研究 被引量:1

Expression and Location of SPINK6 in Human Breast Cancer Cell MCF-7
原文传递
导出
摘要 为探讨Kazal型丝氨酸蛋白酶抑制剂6(SPINK6)蛋白的表达定位与其抗肿瘤作用之间的关系,本文通过免疫荧光的方法研究SPINK6蛋白在不同细胞系中的表达与定位,并构建产生pEGFPN1-SPINK6载体转染至乳腺癌细胞系MCF-7中,使用ER-Tracker标记内质网、lyso-Tracker标记溶酶体、Dil标记细胞膜,共聚焦显微镜观察SPINK6-GFP融合蛋白的定位.结果表明,天然状态的SPINK6蛋白主要分布在细胞质和细胞膜上,并在细胞质中有一定的聚集.对照载体pEGFP-N1转染的细胞表达的绿色荧光主要分布在细胞核中,细胞质中也有均匀分布,而SPINK6-GFP融合蛋白聚集于内质网和细胞膜上.说明SPINK6蛋白在合成后被分泌到细胞膜外发挥其作用,可能与抗炎症与抗肿瘤转移相关. Abstract: To reveal the relationship between the location of Kazal type serine protease inhibitor 6(SPINK6) and its function of anti-tumor. The expression and location of SPINK6 protein were studied by immunofluorescenee. The pEGFPN1-SPINK6 vector was constructed and transfected into MCF-7 cell line, then green fluorescent protein (GFP) was observed together with other organelle markers, including ER-trader, lyso-trader, Dil, by the laser scanning confocal microscopy. Results showed that SPINK6 was mainly located in the cytoplasm and on the cell membrane in natural state. It was showed that green fluorescence protein was distributed in the cell nucleus transfected with pEGFP-N1 vector, but mainly distributed on the plasma membrane and ER transfected with pEGFPN1-SPINK6 vector. The results suggested that SPINK6 protein might be secreted to the outside space of the cell after production, and played roles of anti-inflammatory and anti-tumor functions.
出处 《复旦学报(自然科学版)》 CAS CSCD 北大核心 2015年第1期28-34,F0003,共8页 Journal of Fudan University:Natural Science
基金 国家科技重大专项"重大新药创制"专项(2009ZX09103709 2013ZX09102057)
关键词 丝氨酸蛋白酶抑制剂 SPINK6 亚细胞定位 抗肿瘤 serine protease inhibitor SPINK6 subcellular localization anti-tumor
  • 相关文献

参考文献1

二级参考文献28

  • 1Stenman UH. Tumor-associated trypsin inhibitor. Clin Chem 2002; 48: 1206-9.
  • 2Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C et al. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix rnetalloproteinase-9 but not promatrix metalloproteinase-2 activation. Br J Cancer 2001; 84: 1363-71.
  • 3Hotakainen K, Bjartell A, Sankila A, Jarvinen R, Paju A et al. Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer. Int J Oncol 2006; 28: 95-101.
  • 4Wiksten JP, Lundin J, Nordling S, Kokkola A, Stenman UH et al. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology 2005; 46: 380-8.
  • 5Ateeq B, Tomlins SA, Laxman B, Asangani IA, Cao Q et al. Therapeutic targeting of SPINKl-positive prostate cancer. Sci Transl Med2011; 3: 72ra17.
  • 6Ogawa M, Tsushima T, Ohba Y, Ogawa N, Tanaka S et al. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor. Res Commun Chem Pathol Pharmacol 1985; 50: 155-8.
  • 7Niinobu T, Ogawa M, Murata A, Nishijima J, Mori T. Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor. J Exp Med 1990; 172: 1133-42.
  • 8Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS et al. Overexpression of tumour-associated trypsin in- hibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepa- tocellular carcinoma. Eur J Cancer 2007; 43: 736- 44.
  • 9Gouyer V, Fontaine D, Dumont P, de Wever O, Fontayne-Devaud H et al. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene 2008: 27: 4024-33.
  • 10Gaber A, Johansson M, Stenman UH, Hotakainen K, Ponten F et al. High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer. BrJCancer2009; 100: 1540-8.

共引文献5

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部